© 2022 MJH Life Sciences and Contagion Live. All rights reserved.
© 2022 MJH Life Sciences™ and Contagion Live. All rights reserved.
November 22, 2018
People who inject drugs who are infected with hepatitis C virus can achieve sustained viral response, despite imperfect adherence, according to the results of a new trial.
November 13, 2018
A fixed-dose combination therapy (Vosevi, Gilead) was highly effective after 12 weeks in retreating direct-acting antiviral-experienced patients with hepatitis C virus infection, with and without HIV co-infection, including those with prior noncompletion of treatment or poor adherence.
October 07, 2018
Efforts such as improved indication documentation and antimicrobial stewardship involvement may improve patient outcomes in some patients who are on outpatient parenteral antimicrobial therapy (OPAT) for ease of administration (EOA) that are readmitted to the hospital.
New software to facilitate prior authorization helped streamline the approval process and increase antimicrobial use tracking at the Hospital of the University of Pennsylvania.
August 09, 2018
The combination of direct-acting antiviral agents glecaprevir/pibrentasvir (G/P), sofosbuvir, and ribavirin is now approved for new patient populations.
July 11, 2018
Study results suggest that HPV testing is able to detect cervical intraepithelial neoplasia earlier and more accurately than cytology.
C difficile Awareness Month: Breakthroughs and Setbacks
C difficile, Antimicrobials, and the Patients Most Affected
European Commission Approves Sanofi-GSK COVID-19 Booster VidPrevtyn
Genetic Factors That Naturally Protect Against Severe COVID-19